These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 28917495)

  • 21. Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
    Bilchick KC; Wang Y; Cheng A; Curtis JP; Dharmarajan K; Stukenborg GJ; Shadman R; Anand I; Lund LH; Dahlström U; Sartipy U; Maggioni A; Swedberg K; O'Conner C; Levy WC
    J Am Coll Cardiol; 2017 May; 69(21):2606-2618. PubMed ID: 28545633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.
    Chen TB; Cheng KA; Gao P; Cheng ZW; Fan JB; Jiang XC; Fang Q
    Chin Med J (Engl); 2010 Apr; 123(7):848-51. PubMed ID: 20497676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention.
    Ascoeta MS; Marijon E; Defaye P; Klug D; Beganton F; Perier MC; Gras D; Algalarrondo V; Deharo JC; Leclercq C; Fauchier L; Babuty D; Bordachar P; Sadoul N; Boveda S; Piot O;
    Heart Rhythm; 2016 May; 13(5):1045-1051. PubMed ID: 26749313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Manufacturer change and risk of system-related complications after implantable cardioverter defibrillator replacement: physicians' survey and data from the Detect Long-term Complications After Implantable Cardioverter Defibrillator Replacement Registry.
    Biffi M; Menardi E; Narducci ML; Ammendola E; Messano L; Giofrè F; Baiocchi C; Saporito D; Lissoni F; Bertini M; Pierantozzi A; Zingarini G; Malacrida M; Ziacchi M
    J Cardiovasc Med (Hagerstown); 2017 Dec; 18(12):968-975. PubMed ID: 29028784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
    Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):582-90. PubMed ID: 24002030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex Differences in Outcomes of Tetralogy of Fallot Patients With Implantable Cardioverter-Defibrillators.
    Waldmann V; Bouzeman A; Duthoit G; Koutbi L; Bessière F; Labombarda F; Marquié C; Gourraud JB; Mondoly P; Sellal JM; Bordachar P; Hermida A; Al Arnaout A; Anselme F; Audinet C; Bernard Y; Boveda S; Bun SS; Chassignolle M; Clerici G; Da Costa A; de Guillebon M; Defaye P; Elbaz N; Eschalier R; Garcia R; Guenancia C; Guy-Moyat B; Halimi F; Irles D; Iserin L; Jourda F; Ladouceur M; Lagrange P; Laredo M; Mansourati J; Massoulié G; Mathiron A; Maury P; Messali A; Narayanan K; Nguyen C; Ninni S; Perier MC; Pierre B; Pujadas P; Sacher F; Sagnol P; Sharifzadehgan A; Walton C; Winum P; Zakine C; Fauchier L; Martins R; Pasquié JL; Thambo JB; Jouven X; Combes N; Marijon E
    JACC Clin Electrophysiol; 2022 Oct; 8(10):1304-1314. PubMed ID: 36266008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
    Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implantable cardioverter-defibrillator prescription in the elderly.
    Epstein AE; Kay GN; Plumb VJ; McElderry HT; Doppalapudi H; Yamada T; Shafiroff J; Syed ZA; Shkurovich S;
    Heart Rhythm; 2009 Aug; 6(8):1136-43. PubMed ID: 19539542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.
    Chen CY; Stevenson LW; Stewart GC; Bhatt DL; Desai M; Seeger JD; Williams L; Jalbert JJ; Setoguchi S
    BMJ; 2015 Jul; 351():h3529. PubMed ID: 26174233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry.
    Cheng A; Wang Y; Curtis JP; Varosy PD
    J Am Coll Cardiol; 2010 Nov; 56(20):1651-6. PubMed ID: 21050975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of age on survival and causes of death after primary prevention implantable cardioverter-defibrillator implantation.
    Fauchier L; Marijon E; Defaye P; Piot O; Sadoul N; Perier MC; Gras D; Klug D; Algalarrondo V; Bordachar P; Deharo JC; Leclercq C; Babuty D; Boveda S;
    Am J Cardiol; 2015 May; 115(10):1415-22. PubMed ID: 25784518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes following the implantation of cardioverter-defibrillator for primary prevention in transposition of the great arteries after intra-atrial baffle repair: a single-centre experience.
    Buber J; Ackley TJ; Daniels CJ; Roble SL; Mah ML; Kamp AN; Kertesz NJ
    Europace; 2016 Jul; 18(7):1016-22. PubMed ID: 26705566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lesion-specific differences for implantable cardioverter defibrillator therapies in adults with congenital heart disease.
    Kella DK; Merchant FM; Veledar E; Book W; Lloyd MS
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1492-8. PubMed ID: 24889130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defibrillators in adult congenital heart disease: Long-term risk of appropriate shocks, inappropriate shocks, and complications.
    Moore BM; Cao J; Cordina RL; McGuire MA; Celermajer DS
    Pacing Clin Electrophysiol; 2020 Jul; 43(7):746-753. PubMed ID: 32495949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study.
    Yap SC; Roos-Hesselink JW; Hoendermis ES; Budts W; Vliegen HW; Mulder BJ; van Dijk AP; Schalij MJ; Drenthen W
    Eur Heart J; 2007 Aug; 28(15):1854-61. PubMed ID: 17030523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults.
    Chatrath R; Porter CB; Ackerman MJ
    Mayo Clin Proc; 2002 Mar; 77(3):226-31. PubMed ID: 11888025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous implantable cardioverter-defibrillator: Initial experience.
    Galvão P; Cavaco D; Adragão P; Costa F; Carmo P; Morgado F; Bernardo R; Nunes M; Abecasis M; Neves J; Mendes M
    Rev Port Cardiol; 2014 Sep; 33(9):511-7. PubMed ID: 25242675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.